Myomo, Inc. is a wearable medical robotics company that offers improved arm and hand function for those suffering from neurological disorders and upper-limb paralysis. The Company develops and markets the MyoPro product line, which is a myoelectric-controlled upper limb brace, or orthosis. MyoPro is a powered upper-limb orthosis designed to support the arm and restore function to the weakened or paralyzed arms of certain patients suffering from CVA stroke, brachial plexus injury, traumatic brain or spinal cord injury or other neuromuscular disease or injury. MyoPro senses a patient’s own electromyography (EMG) signals through non-invasive sensors on the arm and can restore an individual’s ability to perform activities of daily living, including feeding themselves, carrying objects and doing household tasks. MyoPro’s control technology utilizes an advanced human-machine interface based on non-invasive, patented electromyography, or EMG, control technology.
公司代碼MYO
公司名稱Myomo Inc
上市日期Jun 12, 2017
CEOGudonis (Paul R)
員工數量184
證券類型Ordinary Share
年結日Jun 12
公司地址137 Portland Street
城市BOSTON
上市交易所NASDAQ OMX – NASDAQ Basic Amex
國家United States of America
郵編02114
電話16179969058
網址https://myomo.com/
公司代碼MYO
上市日期Jun 12, 2017
CEOGudonis (Paul R)